REFERENCES
- Peng CT, Wu JY, Tsai Ch, Molecular diagnosis of patients with β-thalassemia major in central Taiwan by amplified created restriction site analysis. J Hum Genet. 1998; 43(4):237–241.
- Lin KH, Lin KS. Results of therapy for β-thalassemia major. J Formos Med Assoc. 1992; 91(2):126–130.
- Wu KH, Chang JS, Su BH, Peng CT. Tricuspid regurgitation in patients with β-thalassemia major. Ann Hematol. 2004; 83(12):779–783.
- Wu KH, Chang JG, Ho YJ, Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with β-thalassemia major. Hemoglobin. 2006; 30(2):251–256.
- Peng CT, Chow KC, Chen JH, Safety monitoring of cardiac and hepatic systems in β-thalassemia patients with chelating treatment in Taiwan. Eur J Haematol. 2003; 70(6):392–397.
- Wu KH, Chang JS, Tsai CH, Peng CT. Combined therapy with deferiprone and desferrioxamine successfully regress severe heart failure in patients with β-thalassemia major. Ann Hematol. 2004; 83(7):471–473.
- Huang YC, Chang CS, Wu KH, Peng CT. Regression of myocardial dysfunction after switching from deferoxamine to deferiprone in β-thalassemia major patients. Hemoglobin. 2006; 30(2):229–238.
- Peng CT, Wu KH, Wu SF, Deferiprone or deferoxamine versus combination therapy in patients with β-thalassemia major: a case study in Taiwan. Hemoglobin. 2006; 30(1):125–130.
- Peng CT, Tsai CH, Wu KH. Effects of chelation therapy on cardiac function improvement in thalassemia patients: literature review and the Taiwanese experience. Hemoglobin. 2008; 32(1–2):49–62.
- Peng CT, Chang JS, Wu KH, Mechanism of and obstacles to iron cardiomyopathy in thalassemia. Front Biosci. 2008; 13(1):5975–5987.
- Lin KH, Lin KS. Allogeneic bone marrow transplantation for thalassemia in Taiwan: factors associated with graft failure. Am J Pediatr Hematol Oncol. 1989; 11(4):417–423.
- Jaing TH, Wang B, Gjertson D, Unrelated cord blood transplantation for transfusion-dependent thalassemia a CIBMTR audited retrospective analysis of 30 consecutive patients from a single center (abstract 131). Blood. 2008; 112:3885.
- Anderson LJ, Westwood MA, Holden S, Myocardial iron clearance with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004; 127(3):348–355.
- Kontoghiorghes GJ, Eracleous E, Economides Ch, Kolnagou A. Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chlelators ICL670, GT56-252, L1NAII and their combinations. Curr Med Chem. 2005; 12(23):2663–2681.